Valeant Is Said to Hire Zoetis’ Paul Herendeen as CFO

Valeant Pharmaceuticals International Inc. is preparing to name Paul Herendeen, an executive at veterinary drugmaker Zoetis Inc., as its new chief financial officer, according to people familiar with the matter.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.